Corbus Pharmaceuticals Holdings, Inc. (CRBP) › Net IncomeCorbus Pharmaceuticals Holdings, Inc. (CRBP) — Net IncomeAnnual figures by fiscal year, from SEC filings.2013: -$602.4K2014: -$2.54M2015: -$8.85M2016: -$20.00M2017: -$32.42M2018: -$55.67M2019: -$71.45M2020: -$111.27M2021: -$45.64M2022: -$42.35M2023: -$44.60M2024: -$40.21M2025: -$78.54M-$78.54M2013Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$78.54M-95.3%2024-$40.21M+9.9%2023-$44.60M-5.3%2022-$42.35M+7.2%2021-$45.64M+59.0%2020-$111.27M-55.7%2019-$71.45M-28.3%2018-$55.67M-71.7%2017-$32.42M-62.1%2016-$20.00M-126.0%2015-$8.85M-248.4%2014-$2.54M-321.8%2013-$602.4K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share